We are live on
!
Find out more
DCM
Decade Capital Management Portfolio holdings
AUM
$463M
1-Year Est. Return
13.43%
This Fund
S&P 500
This Quarter
Est. Return
+7.11%
1 Year Est. Return
+13.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$809M
AUM Growth
+$225M
(+39%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
23%
Top 10 Holdings %
Top 10 Hldgs %
27.75%
Holding
183
New
57
Increased
42
Reduced
39
Closed
43
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
+$23.4M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$20.5M |
| 3 |
Waters Corp
WAT
|
+$17.6M |
| 4 |
EQT Corp
EQT
|
+$15.3M |
| 5 |
Insulet
PODD
|
+$15.2M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$17.8M |
| 2 |
Quest Diagnostics
DGX
|
+$15.1M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$11.1M |
| 4 |
Accuray
ARAY
|
+$11.1M |
| 5 |
KeyCorp
KEY
|
+$10.5M |
Sector Composition
| 1 | Healthcare | 39.22% |
| 2 | Financials | 16.81% |
| 3 | Energy | 11.14% |
| 4 | Real Estate | 8.81% |
| 5 | Consumer Discretionary | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
1
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $43.4M | 5.36% |
+500,000
| New | +$41.9M |
|
|
SHPG
2
DELISTED
Shire pic
SHPG
| $24.4M | 3.01% |
+101,900
| New | +$23.4M |
|
3
Universal Health Services
UHS
$9.29B
| $23.3M | 2.87% |
197,580
| – | – |
|
|
4
Thermo Fisher Scientific
TMO
$202B
| $21.4M | 2.64% |
+159,177
| New | +$20.5M |
|
|
5
Insulet
PODD
$11.4B
| $21M | 2.59% |
629,100
+450,109
| +251% | +$15.2M |
|
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $20.6M | 2.55% |
+100,000
| New | +$20.6M |
|
7
McKesson
MCK
$98.5B
| $18.9M | 2.34% |
83,602
-7,832
| -9% | -$1.74M |
|
|
8
Waters Corp
WAT
$37.1B
| $18.3M | 2.26% |
+147,337
| New | +$17.6M |
|
|
WBA
9
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $16.9M | 2.09% |
+200,000
| New | +$15.9M |
|
10
Molina Healthcare
MOH
$11.7B
| $16.3M | 2.01% |
242,121
-67,879
| -22% | -$3.92M |
|
|
11
EQT Corp
EQT
$30.9B
| $16.3M | 2.01% |
+360,399
| New | +$15.3M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $15.6M | 1.93% |
+146,589
| New | +$14.4M |
|
|
HOLX
13
DELISTED
Hologic
HOLX
| $15.5M | 1.92% |
469,333
-30,667
| -6% | -$941K |
|
|
WX
14
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $15.1M | 1.87% |
+389,735
| New | +$15M |
|
15
Zoetis
ZTS
$32.2B
| $14.9M | 1.84% |
322,144
+121,754
| +61% | +$5.49M |
|
|
THOR
16
DELISTED
THORATEC CORPORATION
THOR
| $14.5M | 1.79% |
345,900
-110,000
| -24% | -$4.2M |
|
17
Humana
HUM
$46.4B
| $13.9M | 1.71% |
77,908
+30,000
| +63% | +$4.75M |
|
|
NBL
18
DELISTED
Noble Energy, Inc.
NBL
| $13.6M | 1.68% |
+278,027
| New | +$13M |
|
19
Bausch Health
BHC
$1.84B
| $12.9M | 1.6% |
65,000
-10,000
| -13% | -$1.77M |
|
20
Illumina
ILMN
$28.8B
| $12.5M | 1.55% |
69,420
-29,150
| -30% | -$5.49M |
|
21
Edwards Lifesciences
EW
$50.6B
| $12.4M | 1.54% |
+523,644
| New | +$11.7M |
|
22
Zions Bancorporation
ZION
$10.8B
| $12.4M | 1.53% |
457,773
+98,431
| +27% | +$2.58M |
|
|
AMED
23
DELISTED
Amedisys
AMED
| $10.2M | 1.27% |
382,513
+127,614
| +50% | +$3.6M |
|
24
Avanos Medical
AVNS
$1.17B
| $9.84M | 1.22% |
+200,000
| New | +$9.26M |
|
|
HCBK
25
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $9.82M | 1.21% |
937,279
+57,366
| +7% | +$560K |
|
Similar funds
CWA
GACM
BACM
BMCMI
F
TCOTO
CCM
LOCB
Decade Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Decade Capital Management held 183 positions worth $809M, up 39% from $584M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Decade Capital Management deployed $186M of net new capital in Q1 2015, opening 57 new positions and adding to 42 existing holdings. Its largest new stake was Shire pic: 101,900 shares worth $24.4M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Abiomed Inc, an estimated $11.1M trimmed.
- Decade Capital Management's largest Q1 2015 buy was Shire pic: 101,900 shares worth $24.4M.
- Decade Capital Management added most to Insulet in Q1 2015, an estimated $15.2M increase.
- Decade Capital Management's biggest Q1 2015 reduction was Abiomed Inc, cutting an estimated $11.1M.
- Decade Capital Management fully exited CATAMARAN CORP COM STK (CDA) in Q1 2015, selling an estimated $17.8M.
- Decade Capital Management's ten largest holdings make up 28% of its $809M portfolio in Q1 2015.
- Decade Capital Management opened 57 new positions and closed 43 in Q1 2015.
- Decade Capital Management's portfolio value rose 39% quarter-over-quarter to $809M.
Based on Decade Capital Management's 13F filing for Q1 2015, filed 15 May 2015.